Bioteque Corporation (4107.TWO)
TWD 110.0
(-0.9%)
TWD 110.0
(-0.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -459.67 Million TWD | -217.69% |
| 2022 | -144.69 Million TWD | 63.72% |
| 2021 | -398.78 Million TWD | 50.05% |
| 2020 | -798.33 Million TWD | 19.17% |
| 2019 | -987.67 Million TWD | -20.78% |
| 2018 | -817.71 Million TWD | -14.89% |
| 2017 | -711.76 Million TWD | -9.48% |
| 2016 | -650.15 Million TWD | -9.05% |
| 2015 | -596.22 Million TWD | 3.48% |
| 2014 | -617.69 Million TWD | -7.32% |
| 2013 | -575.54 Million TWD | -272.56% |
| 2012 | -154.48 Million TWD | -33.33% |
| 2011 | -115.86 Million TWD | -81.65% |
| 2010 | -63.78 Million TWD | 41.61% |
| 2009 | -109.23 Million TWD | 36.38% |
| 2008 | -171.69 Million TWD | -174.6% |
| 2007 | 230.16 Million TWD | -47.66% |
| 2006 | 439.72 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -707.2 Million TWD | -23.54% |
| 2024 Q1 | -571.98 Million TWD | -24.43% |
| 2023 FY | -459.67 Million TWD | -217.69% |
| 2023 Q3 | -182.44 Million TWD | 40.07% |
| 2023 Q1 | -259.87 Million TWD | -79.61% |
| 2023 Q2 | -304.44 Million TWD | -17.15% |
| 2023 Q4 | -459.67 Million TWD | -151.95% |
| 2022 Q2 | -438.86 Million TWD | -1.87% |
| 2022 Q1 | -430.8 Million TWD | -8.03% |
| 2022 FY | -144.69 Million TWD | 63.72% |
| 2022 Q3 | -29.51 Million TWD | 93.28% |
| 2022 Q4 | -144.69 Million TWD | -390.28% |
| 2021 Q1 | -901.75 Million TWD | -12.95% |
| 2021 Q3 | -434.64 Million TWD | 49.2% |
| 2021 Q4 | -398.78 Million TWD | 8.25% |
| 2021 FY | -398.78 Million TWD | 50.05% |
| 2021 Q2 | -855.55 Million TWD | 5.12% |
| 2020 Q3 | -716.79 Million TWD | 40.35% |
| 2020 Q1 | -1.08 Billion TWD | -10.35% |
| 2020 FY | -798.33 Million TWD | 19.17% |
| 2020 Q2 | -1.2 Billion TWD | -10.25% |
| 2020 Q4 | -798.33 Million TWD | -11.38% |
| 2019 Q3 | -864.66 Million TWD | 15.88% |
| 2019 Q4 | -987.67 Million TWD | -14.23% |
| 2019 FY | -987.67 Million TWD | -20.78% |
| 2019 Q2 | -1.02 Billion TWD | -5.51% |
| 2019 Q1 | -974.19 Million TWD | -19.14% |
| 2018 FY | -817.71 Million TWD | -14.89% |
| 2018 Q4 | -817.71 Million TWD | -23.37% |
| 2018 Q1 | -812.89 Million TWD | -14.21% |
| 2018 Q2 | -896 Million TWD | -10.22% |
| 2018 Q3 | -662.8 Million TWD | 26.03% |
| 2017 Q4 | -711.76 Million TWD | -15.08% |
| 2017 Q2 | -771.64 Million TWD | -9.14% |
| 2017 Q1 | -707.01 Million TWD | -8.74% |
| 2017 FY | -711.76 Million TWD | -9.48% |
| 2017 Q3 | -618.51 Million TWD | 19.85% |
| 2016 FY | -650.15 Million TWD | -9.05% |
| 2016 Q1 | -737.72 Million TWD | -23.73% |
| 2016 Q2 | -742.34 Million TWD | -0.63% |
| 2016 Q3 | -567.47 Million TWD | 23.56% |
| 2016 Q4 | -650.15 Million TWD | -14.57% |
| 2015 FY | -596.22 Million TWD | 3.48% |
| 2015 Q4 | -596.22 Million TWD | 13.45% |
| 2015 Q3 | -688.86 Million TWD | 10.52% |
| 2015 Q2 | -769.82 Million TWD | -7.92% |
| 2015 Q1 | -713.33 Million TWD | -15.48% |
| 2014 Q1 | -635.8 Million TWD | -10.47% |
| 2014 FY | -617.69 Million TWD | -7.32% |
| 2014 Q3 | -527.08 Million TWD | 20.63% |
| 2014 Q2 | -664.1 Million TWD | -4.45% |
| 2014 Q4 | -617.69 Million TWD | -17.19% |
| 2013 Q2 | -307.12 Million TWD | -11.93% |
| 2013 Q3 | -402.55 Million TWD | -31.07% |
| 2013 Q4 | -575.54 Million TWD | -42.97% |
| 2013 FY | -575.54 Million TWD | -272.56% |
| 2013 Q1 | -274.38 Million TWD | -77.61% |
| 2012 Q1 | -123.09 Million TWD | -6.24% |
| 2012 Q2 | -152.02 Million TWD | -23.5% |
| 2012 Q3 | -142.13 Million TWD | 6.5% |
| 2012 Q4 | -154.48 Million TWD | -8.69% |
| 2012 FY | -154.48 Million TWD | -33.33% |
| 2011 Q2 | -91.36 Million TWD | 16.57% |
| 2011 Q3 | -95.95 Million TWD | -5.03% |
| 2011 Q4 | -115.86 Million TWD | -20.75% |
| 2011 FY | -115.86 Million TWD | -81.65% |
| 2011 Q1 | -109.51 Million TWD | -71.7% |
| 2010 Q4 | -63.78 Million TWD | 0.0% |
| 2010 FY | -63.78 Million TWD | 41.61% |
| 2009 FY | -109.23 Million TWD | 36.38% |
| 2008 FY | -171.69 Million TWD | -174.6% |
| 2007 FY | 230.16 Million TWD | -47.66% |
| 2006 FY | 439.72 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | -1.4 Billion TWD | 67.199% |
| Chi Sheng Pharma & Biotech Co., Ltd | -261.04 Million TWD | -76.088% |
| Sunder Biomedical Tech. Co., Ltd. | 394.6 Million TWD | 216.491% |
| BenQ Medical Technology Corporation | 405.72 Million TWD | 213.298% |
| Pacific Hospital Supply Co., Ltd | -307.54 Million TWD | -49.464% |
| Unicon Optical Co., Ltd. | 41.06 Million TWD | 1219.302% |
| Formosa Optical Technology Co.,Ltd. | 2.78 Billion TWD | 116.513% |
| Medeon Biodesign, Inc. | -1.19 Billion TWD | 61.398% |
| Concord Medical Co., Ltd. | 104.78 Million TWD | 538.701% |
| Crystalvue Medical Corporation | -248.31 Million TWD | -85.115% |
| Perfect Medical Industry Co., Ltd. | 50.55 Million TWD | 1009.311% |
| ICARES Medicus, Inc. | -259.62 Million TWD | -77.051% |
| Lagis Enterprise Co., Ltd. | 87.79 Million TWD | 623.572% |
| Amed Co., Ltd. | 153.75 Million TWD | 398.974% |